1-8 of 8
Gisela Barbany, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNA Methylation-Based Subtype Prediction for Pediatric Acute Lymphoblastic Leukemia (ALL)

Jessica Nordlund, PhD, Christofer Bäcklin, MSc, Vasilios Zachariadis, MD, Lucia Cavelier, PhD, Johan Dahlberg, MSc, Ingegerd Öfverholm, MD, Gisela Barbany, MD PhD, Ann Nordgren, MD PhD, Elin Övernäs, PhD, Jonas Abrahamsson, MD PhD, Trond Flaegstad, MD PhD, Mats Heyman, MD PhD, Ólafur G Jónsson, MD, Jukka A. Kanerva, MD, Rolf Larsson, MD PhD, Josefine Palle, MD PhD, Kjeld Schmiegelow, Mats G Gustafsson, PhD, Gudmar Lönnerholm, MD PhD, Erik Forestier, MD PhD, Ann-Christine Syvänen, PhD
Journal: Blood
Blood (2014) 124 (21): 490.
https://doi.org/10.1182/blood.V124.21.490.490
Published: 2014
Journal Articles

Novel Focal Gene Deletions in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Detected By Array Comparative Genomic Hybridization

Ingegerd Ivanov Öfverholm, MD, Anh Nhi Tran, PhD, Vasilios Zachariadis, MD, Mats Heyman, MD PhD, Eva Rudd, MD PhD, Elisabeth Syk Lundberg, MD PhD, Magnus Nordenskjöld, MD, PhD, Ann Nordgren, MD PhD, Gisela Barbany, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1085.
https://doi.org/10.1182/blood.V124.21.1085.1085
Published: 2014
Journal Articles

Leukemic Stem Cell Quantification Is Of Prognostic Value In Newly Diagnosed Patients In Chronic Phase Chronic Myeloid Leukemia (CML-CP) Receiving Nilotinib Therapy: Results From The ENEST1st Stem Cell Substudy

Noortje Thielen, MD, Johan Richter, MD, PhD, Gisela Barbany, MD PhD, Thoas Fioretos, MD PhD, Frank Giles, MD MB, Bjorn T Gjertsen, MD PhD, Andreas Hochhaus, MD, Gert J. Ossenkoppele, MD PhD, Kimmo Porkka, MD, PhD, Gerrit Jan Schuurhuis, PhD, Sieghart Sopper, PhD, Leif Stenke, MD, PhD, Sara Thunberg, PhD, Dominik Wolf, MD, Jeroen Janssen, MD PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 649.
https://doi.org/10.1182/blood.V122.21.649.649
Published: 2013
Journal Articles

Favorable Therapeutic Responses in Newly Diagnosed CML-CP Patients Induced by Dasatinib Are Reflected At the CD34+CD38+ Progenitor Cell but Not At the CD34+CD38− Stem Cell Level: Results From Randomized NordCML006 Study

Satu Mustjoki, MD, PhD, Johan Richter, MD, PhD, Gisela Barbany, MD, PhD, Hans Ehrencrona, MD, PhD, Ingunn Dybedal, MD, PhD, Thoas Fioretos, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Bjorn Gjertsen, MD, PhD, Randi Hovland, PhD, Sari E Jalkanen, MSc, Dag Josefsen, MD, PhD, Perttu Koskenvesa, MD, Carin Lassen, Msc, Kirsi Latvala, Waleed Majeed, MD, Claes Malm, MD, Berit Markevärn, MD, Ali Mosfegh, PhD, Lotta Ohm, MD, Tor Olofsson, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Katrin Rapakko, PhD, Kari Remes, MD PhD, Jesper Stentoft, MD, PhD, Leif Stenke, MD, PhD, Merja Suominen, MD, Sara Thunberg, PhD, Ole Weiss Bjerrum, MD, PhD, Bengt Simonsson, MD, PhD, Kimmo Porkka, MD, PhD, Henrik Hjorth-Hansen, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 784.
https://doi.org/10.1182/blood.V118.21.784.784
Published: 2011
Journal Articles

Landmark Analysis of Imatinib Treatment in CML Chronic Phase: ES-FISH <10% Ph+ At 3 Months Associated with Better Cytogenetic Response and Improved Long-Term Event-Free Survival

Anne-Charlotte Ohm, M.D., Gisela Barbany, MD, PhD, Ingrid Arvidsson, Lab., tech., Robert Hast, M.D., Ph.D., Leif Stenke, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1702.
https://doi.org/10.1182/blood.V118.21.1702.1702
Published: 2011
Journal Articles

The Proportion of Ph+ CD34 + CD38 neg Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI-Therapy. Data From a Randomized Phase II NordCML006 Study

Satu Mustjoki, MD, PhD, Johan Richter, MD, PhD, Gisela Barbany, MD, PhD, Ingunn Dybedal, MD, PhD, Thoas Fioretos, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Bjorn T. Gjertsen, MD, PhD, Randi Hovland, PhD, Sari Jalkanen, Msc, Dag Josefsen, MD, PhD, Perttu Koskenvesa, MD, Carin Lassen, Kirsi Latvala, Waleed Majeed, MD, Claes Malm, MD, Berit Markevärn, MD, Ali Moshfegh, PhD, Lotta Ohm, MD, Tor Olofsson, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Katrin Rapakko, PhD, Kari Remes, MD, PhD, Jesper Stentoft, MD, PhD, Leif Stenke, MD, PhD, Merja Suominen, MD, Sara Thunberg, MD, PhD, Ole Weiss Bjerrum, MD, PhD, Bengt Simonsson, MD, PhD, Kimmo Porkka, MD, PhD, Henrik Hjorth-Hansen, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 667.
https://doi.org/10.1182/blood.V116.21.667.667
Published: 2010
Journal Articles

Identification of Genes That Potentially Allow Prediction of Interferon Response in Chronic Phase CML Diagnostic Samples through Gene Expression Analysis.

Gisela Barbany, MD, PhD, Anette Hagberg, PhD, Ulla Strömberg-Olsson, MD, Anders Isaksson, PhD, Mats Bengtzon, MD, PhD, Martin Höglund, MD, PhD, Bengt Simonsson, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 4832.
https://doi.org/10.1182/blood.V106.11.4832.4832
Published: 2005
Journal Articles

Microarray Gene Expression Studies Reveal Potential Classifier Genes That Allow Prediction of Response to Interferon in Chronic Myeloid Leukemia Patients.

Gisela Barbany, MD PhD, Anette Hagberg, PhD, Ulla Olsson Strömberg, MD, Anders Isaksson, PhD, Bengt Simonsson, MD PhD
Journal: Blood
Blood (2004) 104 (11): 4409.
https://doi.org/10.1182/blood.V104.11.4409.4409
Published: 2004